PERSEN MALCOLM C 4
4 · NEPHROS INC · Filed Dec 18, 2018
Insider Transaction Report
Form 4
NEPHROS INCNEPH
PERSEN MALCOLM C
Director
Transactions
- Award
Common Stock
2018-12-14+71,509→ 336,750 total
Holdings
- 33,880
Stock Option (Right to Buy)
Exercise: $0.40Exp: 2026-08-24→ Common Stock (33,880 underlying) - 15,580(indirect: By Spouse)
Warrants (right to buy)
Exercise: $0.85From: 2015-05-12Exp: 2020-05-18→ Common Stock (15,580 underlying) - 56,981
Stock Option (Right to Buy)
Exercise: $0.79Exp: 2025-05-07→ Common Stock (56,981 underlying) - 40,284
Stock Option (Right to Buy)
Exercise: $0.50Exp: 2027-12-20→ Common Stock (40,284 underlying) - 31,160(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]On December 14, 2018, the Company granted 71,509 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Persen in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
- [F2]Fully exercisable.
- [F3]The option vests as to 13,428 shares on each of 12/20/17, 12/20/18 and 12/20/19.